Cancer & Cardiovascular Disease: Impacts at All Ages

03/19/24 • 36 min

While cancer survivorship rates continue to improve, there are CVD-related complications for patients before, during, and after cancer treatment. Guests Chelsea Kriesberg, DNP, CPNP-AC, CCRN, and Lisa Nodzon, PhD, APRN, AOCNP, describe the intersection of cancer and cardiovascular disease across the lifespan. Collaborative, team-based, and life-long care is illustrated in through a case-based discussion.

Cardiovascular risk calculator: https://ccss.stjude.org/resources/calculators/cardiovascular-risk-calculator.html

Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance. Leerink, J, de Baat, E, Feijen, E. et al. Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: JACC CardioOncology State-of-the-Art Review. J Am Coll Cardiol CardioOnc. 2020 Sep, 2 (3) 363â€“378.https://doi.org/10.1016/j.jaccao.2020.08.006

Cardioprotective impacts of dexrazoxane: Lipshultz SE, Scully RE, Lipsitz SR, et al. Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. Lancet Oncol. 2010 Oct;11(10):950-61. doi: 10.1016/S1470-2045(10)70204-7. Epub 2010 Sep 16. PMID: 20850381; PMCID: PMC3756093.

Improving quality and quantity of life for childhood cancer survivors: Ehrhardt MJ, Krull KR, Bhakta N, et al. Improving quality and quantity of life for childhood cancer survivors globally in the twenty-first century. Nat Rev Clin Oncol. 2023 Oct;20(10):678-696. doi: 10.1038/s41571-023-00802-w. Epub 2023 Jul 24. PMID: 37488230.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Cardiovascular risk calculator: https://ccss.stjude.org/resources/calculators/cardiovascular-risk-calculator.html

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Previous Episode

Inflammation and Cardiovascular Disease: Evidence-Based Treatments

Treating inflammation in cardiovascular disease includes helping patients to understand the safety and efficacy of prescription and over-the-counter products. Joseph Saseen, Pharm D, FNLA, CLS discusses best practices in clinical decision-making, mechanisms of action , and guideline-based evidence for various anti-inflammatory medications.

2023 AHA/ACC Guideline for the Management of Patients with Chronic Coronary Disease: https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000001168

CANTOS trial: https://www.nejm.org/doi/full/10.1056/nejmoa1707914

ACC guidelines & clinical documents: https://www.acc.org/Guidelines

ICER (Institute for Clinical and Economic Review): https://icer.org/

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Next Episode

Partnering with Patients, Families, and Colleagues in Secondary Prevention

Effective strategies for maximizing both inpatient and outpatient cardiac rehab are discussed by guest Jonathan David, MSN, RN, EBP-C, CCRP, NE-BC, AACC. Highlights include using a team-based approach, engaging patients in shared decision-making, providing a continuum of care that maximizes patient outcomes, and advocating for cardiovascular care.

PCNA Patient Education tool: Leaving the Hospital After Your Heart Attack: https://pcna.net/clinical-resources/patient-handouts/acute-coronary-syndrome-tools-and-handouts/

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.